Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
about
Comparison of hepatitis B viral loads and viral antigen levels in child-bearing age women with and without pregnancy.Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New OpportunitiesCurrent evidence on the management of hepatitis B in pregnancyEfficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads
P2860
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
@en
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
@nl
type
label
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
@en
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
@nl
prefLabel
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
@en
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
@nl
P2093
P2860
P50
P356
P1476
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
@en
P2093
Aram Limtrakul
Camlin Tierney
Chaiwat Putiyanun
Chureeratana Bowonwatanuwong
Diane H Watts
George K Siberry
Jullapong Achalapong
Linda Harrison
Nahida Chakhtoura
Nantasak Chotivanich
P2860
P304
P356
10.1056/NEJMOA1708131
P407
P577
2018-03-01T00:00:00Z